Table 1 Associations (χ2-tests/Fischers exact test) between the protein expression of ADAM9 in renal cell cancer and clinico-pathological parameters (percentages in brackets)
From: ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
| Â | Total | low ADAM9 | high ADAM9 | p-value |
|---|---|---|---|---|
All cases | 108 (100) | 71 (65.7) | 37 (34.3) | Â |
Age | Â | Â | Â | 0.225 |
≤ 62 | 59 (54.6) | 42 (71.2) | 17 (28.8) |  |
> 62 | 49 (45.4) | 29 (59.2) | 20 (40.8) | Â |
Histology | Â | Â | Â | < 0.001 |
Clear cell | 86 (79.6) | 65 (75.6) | 21 (24.4) | Â |
chromophobe | 5 (4.6) | 2 (40.0) | 3 (60.0) | Â |
Papillary | 17 (15.7) | 4 (23.4) | 13 (76.5) | Â |
pT-status | Â | Â | Â | 0.104 |
pT1 | 54 (50.0) | 40 (74.1) | 14 (25.9) | Â |
pT2/3/4 | 54 (50.0) | 31 (57.4) | 23 (42.6) | Â |
pN-status* | Â | Â | Â | 0.022 |
pN0 | 51 (47.2) | 36 (70.6) | 15 (29.4) | Â |
pN1 | 12 (11.1) | 4 (33.3) | 8 (66.7) | Â |
Grading | Â | Â | Â | 0.002 |
G 1 | 11 (10.2) | 11(100) | 0 (0) | Â |
G 2 | 75 (69.4) | 50 (66.7) | 25 (33.3) | Â |
G 3/4 | 22 (20.4) | 10 (45.5) | 12 (54.5) | Â |
Residual tumour status # | Â | Â | Â | 0.073 |
R0 | 78 (72.2) | 56 (71.8) | 22 (28.2) | Â |
R1/2 | 15 (13.9) | 7 (46.7) | 8 (53.3) | Â |
Metastasis | Â | Â | Â | 0.014 |
M0 | 85 (78.7) | 61 (71.8) | 24 (28.2) | Â |
M1 | 23 (21.3) | 10 (43.5) | 13 (56.5) | Â |